Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alexander Abitbol, MD
LMC Clinical Research
Principal Investigator - Asheesh Dewan, MD
The Docs LLC
Principal Investigator - Barry Reiner, MD
Barry J Reiner MD LLC
Principal Investigator - Bhuvana Sunil, MD
MultiCare Institute for Research & Innovation
Principal Investigator - Bruce King, MD
John Hunter Childrens Hospital
Principal Investigator - Carla Demeterco-Berggren, MD
Rady's Children's Hospital
Principal Investigator - Daniele Pacaud, MD
Alberta Children's Hospital Research Institute
Principal Investigator - David Liljenquist, MD
Rocky Mountain Clinical Research
Principal Investigator - Dorothy Shulman, MD
University of South Florida
Principal Investigator - Frances Broyles, MD
Rainier Clinical Research Center
Principal Investigator - Gnanagurudasan Prakasam, MD
Sutter Institute for Medical Research
Principal Investigator - Halis Akturk, MD
University of Colorado, Denver
Principal Investigator - James Thrasher, MD
Medical Investigations, Inc.
Principal Investigator - John Reed, MD
Endocrine Research Solutions
Principal Investigator - Mark Kipnes, MD
Diabetes and Glandular Disease Clinic, P.A.
Principal Investigator - Paul Norwood, MD
Valley Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- John Hunter Childrens Hospital
New Lambton, New South Wales, Australia
- Alberta Children'S Hospital Research Institute
Calgary, Alberta, Canada
- Lmc Clinical Research
Toronto, Ontario, Canada
- Medical Investigations, Inc.
Little Rock, Arkansas, United States
- Valley Research
Fresno, California, United States
- Sutter Institute for Medical Research
Sacramento, California, United States
- Rady'S Children'S Hospital
San Diego, California, United States
- Barbara Davis Center for Diabetes
Aurora, Colorado, United States
- University of South Florida
Tampa, Florida, United States
- Atlanta Diabetes Associates
Atlanta, Georgia, United States
- Endocrine Research Solutions
Roswell, Georgia, United States
- Rocky Mountain Clinical Research
Idaho Falls, Idaho, United States
- Barry J Reiner Md, Llc
Baltimore, Maryland, United States
- the Docs, Llc
Las Vegas, Nevada, United States
- Physicians East
Greenville, North Carolina, United States
- Diabetes and Glandular Disease Clinic, P.A.
San Antonio, Texas, United States
- Rainier Clinical Research Center
Renton, Washington, United States
- Multicare Institute for Research & Innovation
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Mar 2022
- Primary completion
- 21 Jun 2024
- Completion
- 21 Jun 2024
- Last update posted
- 22 Jun 2025
- Registered enrollment
- 240
- Registry id
- NCT05224258
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.